Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence

NCT01479244 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

758

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer With Low to Intermediate HER2 Expression

Interventions

BIOLOGICAL: NeuVax™ vaccine
BIOLOGICAL: Leukine® (sargramostim, GM-CSF) and water for injection

Sponsor

Galena Biopharma, Inc.